<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":1050,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
United States v. Boros, 668 F.3d 901 (7th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/dca4362e458aae3a923324d93b2455ff'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/dca4362e458aae3a923324d93b2455ff'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1H4JHM003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1H4JHM003">Previous Result: <span>Mobley v. Harris, CASE NO. 5:11-cv-183-R...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1H4JHO003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1H4JHO003">Next Result: <span>Begay v. United States, CASE NO. 5:11-cv...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='United States v. Boros, 668 F.3d 901 (7th Cir. 2012), Court Opinion'>
United States v. Boros, 668 F.3d 901 (7th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>United States v. Boros, 668 F.3d 901 (7th Cir. 2012), Court Opinion</div>
<div class='docId'>X1H4ECA003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>United States v. Boros</div>
<div class='displayCitation'>2012 BL 29839</div>
<div class='displayCitation'>2012 BL 35185</div>
<div class='displayCitation'>668 F.3d 901</div>
<div class='displayCitation'>wkf7case:25763013</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1H4ECA003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="United States v. Boros, 668 F.3d 901 (7th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="United States v. Boros" />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1H4ECA003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1H4ECA003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1H4ECA003" /><input id="title" name="title" type="hidden" value="United States v. Boros, 668 F.3d 901 (7th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="dca4362e458aae3a923324d93b2455ff" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1H4ECA003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2Fdca%34%33%36%32e%34%35%38aae%33a%39%32%33%33%32%34d%39%33b%32%34%35%35ff%2Fdocument%2FX%31H%34ECA%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/bcite/X1H4ECA003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/bcite/X1H4ECA003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/bcite/X1H4ECA003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/related_content/X1H4ECA003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1688404819971";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">668 F.3d 901</div>
<div class="cite" data-cite-type="DocketNumber">10-2566</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 35185</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Seventh Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
UNITED STATES of America, Plaintiff-Appellee, v. Ricky BOROS,
Defendant-Appellant.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 10-2566.
</center></p>
<p><center>
Argued October 19, 2011.
</center></p>
<p><center>
Decided February 9, 2012.
</center></p>
<div id="para2" printdualcolumn="true"><p>
  Appeal from the United States District Court for the
Northern District of Illinois, Joan B. Gottschall, J.
</p></div>
<span CLASS="page_no" data-cite="668 f 3d 902" data-cite-type="PrimaryFederalReporter" data-cite-pageno="902" data-primary-citation="668 F.3d 901">[*902]</span> <div id="para2" printdualcolumn="true"><p>
  Matthew Hiller (argued), Attorney, Office of the United
States Attorney, Chicago, IL, for Plaintiff-Appellee.
<span CLASS="page_no" data-cite="668 f 3d 903" data-cite-type="PrimaryFederalReporter" data-cite-pageno="903" data-primary-citation="668 F.3d 901">[*903]</span> 
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Michael Bernard Nash (argued), Attorney, Chicago, IL, for
Defendant-Appellant.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Before FLAUM and MANION, Circuit Judges, and
MAGNUS-STINSON, District Judge.<a HREF="#fn*00" name="fnref_fn*00">[fn*]</a>
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span class="fr"><a HREF="#fnref_fn*00" name="fn*00">[fn*]</a></span> The Honorable Jane E. Magnus-Stinson, District Judge for
the United States District Court for the Southern District of
Indiana, sitting by designation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  FLAUM, Circuit Judge.
</p></div>
<div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Ricky Boros, also known as Vince Kwiatkowski, appeals his
convictions for conspiracy to import controlled substances,
conspiracy to possess controlled substances with the intent to
distribute, and conspiracy to launder money with the intent to
promote the importation of controlled substances. The sole
argument that he makes on appeal is that the district court
erred by admitting the expert testimony of pharmacologist Dr.
Robert Barkin. Dr. Barkin testified about the classification of
various drugs, their side effects, and the medical supervision
needed to prescribe them. Boros contends that this evidence was
not relevant as defined by Federal Rule of Evidence <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">401</a> and
that its admission was not harmless. We disagree. Although the
testimony had only minimal relevance, the threshold for
relevance under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a> is quite low. The parts of the
testimony related to side effects and birth defects, however,
should have been excluded under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a>. Because the probative
value was negligible, this testimony's potential for unfair
prejudice to Boros should have tipped the scales in favor of
exclusion. Nonetheless, we find this error to be harmless given
the weight of the government's evidence. We therefore affirm
the judgment of the district court.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                              <b>I. Background</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>A. Factual Background</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Boros, along with Larry and Gary Calow,<a HREF="#fn100" name="fnref_fn100">[fn1]</a> founded an
Internet pharmacy business in March 2003, which they
incorporated in Belize under the name Purchase Meds, Inc.
("PMeds").<a HREF="#fn200" name="fnref_fn200">[fn2]</a> PMeds sold prescription drugs, including
controlled substances, to customers via its website, PMeds.com.
A handwritten "letter of intent" memorialized its formation,
the initial distribution of shares, and the roles of the
founders. Boros assumed the role of corporate secretary. The
Calows worked from Mexico and Tinley Park, Illinois, and Boros
worked from his home in Oak Brook, Illinois. By 2006, PMeds had
gross sales in excess of $5.5 million.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although the website took orders for prescription medication,
it did not require customers to have prescriptions. As of April
14, 2003, the website stated, "[I]f you do not supply a
prescription, we will supply a prescription at no cost to you."
As of June 27, 2004, the website promised to provide a "free
online consultation with a licensed U.S. physician" to obtain
prescription medication. The website required purchasers of
controlled substances to disclaim their affiliation with
government and news agencies. PMeds disclaimed responsibility
for confirming importation regulations <span CLASS="page_no" data-cite="2012 bl 35185 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> and placed the risk of
loss on customers unless U.S. Customs provided seizure
notification and proof of reclaim.
<span CLASS="page_no" data-cite="668 f 3d 904" data-cite-type="PrimaryFederalReporter" data-cite-pageno="904" data-primary-citation="668 F.3d 901">[*904]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Boros's responsibilities for PMeds included advertising,
directing website traffic, analyzing sales and inventory,
negotiating prices with distributors, and obtaining
prescriptions for orders stopped at the U.S.-Mexico border.
Boros sent several emails to the Calows in 2003 and 2004 that
referenced drug sales, including the sale of controlled
substances. A spreadsheet attached to one of the emails listed
the names and quantities of 235 products, including controlled
substances, that PMeds had sold in the last three months. Boros
picked up checks for PMeds on a weekly basis from the Tinley
Park office, deposited them into his account, and gave the cash
to Gary. Boros also received cash payments. His active
participation with PMeds appears to have ended in mid-2004.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Joshua Morrow and Angela Burdick both worked for PMeds and
later served as witnesses for the government. Morrow was
initially a customer of PMeds and then started smuggling drugs
for PMeds. He was arrested in 2005 for attempting to drive 200
packages of drugs into the United States. Burdick worked for
PMeds in 2003 and was given a grant of immunity in exchange for
her testimony about PMeds and the defendants' activities.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 2006, the Drug Enforcement Administration ("DEA") conducted
several undercover purchases of controlled substances through
PMeds's website. In October 2006, law enforcement officers,
accompanied by a DEA forensic chemist, executed a search
warrant at the Tinley Park office and found flasks, spa oil
bottles, a vacuum pump, and a vacuum filter flask. Forensic
testing detected numerous types of steroids. In January 2007,
Mexican police searched Alfa Pack Shipping Services in Metepec,
Mexico, and found an invoice for spa oil bottles to be shipped
from Gary's wife to Larry in Tinley Park. Further, IRS Special
Agent William Desmond reviewed the records of the two bank
accounts associated with PMeds. He found that fifteen credit
card companies had transferred more than $5.5 million into the
two accounts between May 15, 2003 and December 4, 2006, that
nearly $2.5 million was wired from these accounts to Latin
America, and that $47,074.32 was wired from these two accounts
to Boros between December 30, 2003 and July 16, 2004.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On August 8, 2007, a grand jury returned a superseding
indictment<a HREF="#fn300" name="fnref_fn300">[fn3]</a> against Boros and five other defendants for
conspiracy to import Schedule II, III, and IV controlled
substances, in violation of <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976I2003?jcsearch=21%20usc%20963&amp;summary=yes#jcite">21 U.S.C. &sect; 963</a> and
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHREQ003?jcsearch=18%20usc%202&amp;summary=yes#jcite">18 U.S.C. &sect; 2</a>; conspiracy to possess controlled substances with the
intent to distribute, in violation of <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976DK003?jcsearch=21%20usc%20846&amp;summary=yes#jcite">21 U.S.C. &sect; 846</a> and
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHREQ003?jcsearch=18%20usc%202&amp;summary=yes#jcite">18 U.S.C. &sect; 2</a>; money laundering, in violation of
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHSRQ003?jcsearch=18%20usc%201957&amp;summary=yes#jcite">18 U.S.C. &sect; 1957</a> and <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHREQ003?jcsearch=18%20usc%202&amp;summary=yes#jcite">18 U.S.C. &sect; 2</a>; and conspiracy to launder
money out of the United States with the intent to promote the
importation, possession, and distribution of controlled
substances, in violation of <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHSRO003?jcsearch=18%20usc%201956&amp;summary=yes#jcite">18 U.S.C. &sect; 1956</a> and
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHREQ003?jcsearch=18%20usc%202&amp;summary=yes#jcite">18 U.S.C. &sect; 2</a>. The government subsequently dismissed the substantive
money laundering charges.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>B. Procedural Background</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The government disclosed prior to trial that it intended to
call Dr. Barkin, a clinical pharmacologist, <span CLASS="page_no" data-cite="2012 bl 35185 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> as an expert
witness in clinical pharmacy. Boros filed a motion in limine to
bar this testimony, arguing that evidence about the dangers of
taking controlled substances without medical supervision "is a
scare tactic without probative
<span CLASS="page_no" data-cite="668 f 3d 905" data-cite-type="PrimaryFederalReporter" data-cite-pageno="905" data-primary-citation="668 F.3d 901">[*905]</span> 
value." The district court found the motion to be untimely
but still expressed some reservations:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I'm going to allow this, but keep it under control. In
  other words, I don't want this to be inflammatory. If
  he wants to just testify that the drug has side
  effects, that when it's prescribed &mdash; whatever
  he's going to testify to, a doctor can watch the
  prescription, etcetera, but I don't want this to get
  out of control and have him testifying about the
  terrible things that can happen to people if they take
  these drugs without a prescription, except indicating
  it factually, and briefly, and succinctly.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
The district court placed the onus on the defense to object if
it perceived the testimony to cross the line established by the
evidentiary ruling.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  After the government tendered Dr. Barkin as an expert, Boros's
counsel reminded the court of its pre-trial ruling and the
court held a sidebar. Boros's counsel argued that Dr. Bar kin
should not "be out there raising prejudices about how terrible
it is to take medicines without a prescription, that there's
danger in taking medicine without a prescription, because
that's got nothing to do with what we're on trial for." The
government responded that Dr. Barkin would "address a number of
controlled substances that PMeds dealt with, and talk about
them, and the need for medical supervision and prescriptions,
and the effects on people." The court viewed the matter as a
question of "for how long and in what detail are we going to
wallow in it" and held that "the jury is entitled to know,
without going . . . into great, great detail on this, why these
subjects are regulated and what the issues are about them. . . .
I think if there is an issue, it's a 403 issue."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Barkin began with the schedule of controlled substances,
explaining the significance of the numerals and the
classification of various drugs. He then discussed the
Physician Desk Reference ("PDR"), which was admitted without
objection. Dr. Barkin read aloud parts of the PDR pertaining to
Schedules II, III, and IV, which discuss the requirements for
prescriptions of specific substances and the risk of abuse. For
example, he quoted the PDR as stating that the use of
substances in Schedule II "may lead to severe physical or
psychologic depend[e]nce. Prescriptions must be written in ink,
or typewritten, signed by the practitioner. Verbal
prescriptions must be confirmed in writing within 72 hours, and
may be given only in a genuine emergency. No renewals are
permitted."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Barkin continued by addressing the factors that physicians
consider prior to prescribing controlled substances,
specifically referencing the procedures followed by his
employer, the Rush Pain Center. He testified about the need to
meet with patients in person and to determine the correct
dosage on an individual basis. He explained that dosage depends
on the patient's kidney <span CLASS="page_no" data-cite="2012 bl 35185 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> and liver function, weight, height,
other medications being taken, and child-bearing potential. Dr.
Barkin emphasized that this could not be done over the
Internet.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Next, Dr. Barkin addressed thirteen specific drugs or types of
drugs, explaining whether they are controlled substances,<a HREF="#fn400" name="fnref_fn400">[fn4]</a>
how they are scheduled, why they are prescribed, and why a
prescription is needed.<a HREF="#fn500" name="fnref_fn500">[fn5]</a>
<span CLASS="page_no" data-cite="668 f 3d 906" data-cite-type="PrimaryFederalReporter" data-cite-pageno="906" data-primary-citation="668 F.3d 901">[*906]</span> 
Dr. Barkin testified that Ritalin is a Schedule II
controlled substance used to address Attention Deficit
Disorder. He explained that use of Ritalin requires in-person
monitoring and that users should not crush or snort it. He
warned that use of Ritalin could result in birth defects and
psychotic episodes, as well as "[d]rug dependence, abnormal
thinking, and abnormal behaviors, frank psychotic episodes." In
discussing Valium, Ativan, and Xanax, Dr. Barkin identified the
severe risk of birth defects and the danger of seizures if a
patient abruptly stops taking these substances. He testified
that Rohypnol is an "extremely fast onset sedative hypnotic"
that is not available in United States and that causes a user
to become "completely disinhibited, helpless, very sedated"
with a "complete lack of recall and memory." Dr. Barkin
explained that Clenbuterol, used to treat asthma and to
strengthen animals, is not a controlled substance but is
nonetheless unavailable in the United States due to "tremendous
risks."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Barkin described anabolic steroids in greater detail,
beginning with their Schedule III classification and their use
in treating testosterone deficiency, breast cancer, and
prostate cancer. He cautioned that users must be monitored due
to the severity of the potential side effects, which include
large breasts for males, virilization in women, agitation,
anger, violence, episodic discontrol, cardiac disease, increase
in cholesterol, birth defects, coagulation problems, adverse
effects on the liver, and stunted growth for teens. He referred
to Phentermine, Didrex, and Bontril as controlled substances
that are used as appetite suppressants. Dr. Barkin focused on
the risks of Ambien and Halcion, both Schedule IV controlled
substances that are used as sleep aids. Before prescribing
Ambien, physicians counsel the patient to determine the cause
of the insomnia and take into account the patient's liver
function, kidney function, psychopathology, and alcohol usage.
Halcion comes with side effects of birth defects and fast-onset
memory impairment and judgment problems. Dr. Barkin noted that
Halcion has "grown into substantial disuse" due to the severity
of these side effects. Finally, Dr. Barkin described the
weight-loss drug, Meridia, which requires monitoring because it
can cause seizures and affects the rate, rhythm, conduction,
and contractility of the heart.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  During cross-examination, Dr. Barkin admitted that he does not
know who the clients are or have any personal knowledge of the
facts of this case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In its closing argument, the government emphasized Dr. Barkin's
testimony, connecting it to the offenses charged in the
following manner:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  He told <span CLASS="page_no" data-cite="2012 bl 35185 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> you how important it is to be under the care
  of a physician when taking controlled substances like
  Ritalin, and Ambien, and anabolic steroids. He also
  told you that those substances can harm pregnant
  woman. He said that some of the drugs that were sold
  by PMeds, like Rohypnol, are so dangerous that they
  aren't even allowed to be sold in the United States.
  No doctor can prescribe Rohypnol. But you can get
  Rohypnol from Pmeds.com. . . .
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Now, use your common sense here. Vince Kwiatkowski is
  excited about selling illegal drugs. He says that they
  haven't shipped all their orders. He[] knows what[`s]
  going on with the business. He knows what drugs
  they're selling. He knows what dangerous, illegal,
  controlled substances they need more of. Drugs like
  steroids and Xanax. Those are some of the drugs that
<span CLASS="page_no" data-cite="668 f 3d 907" data-cite-type="PrimaryFederalReporter" data-cite-pageno="907" data-primary-citation="668 F.3d 901">[*907]</span> 
  Dr. Barkin told you should never be used
  without a doctor's prescription or without a doctor's
  care. He told you they're dangerous drugs. He told you
  that they're addictive, and he told you that they have
  harmful side effects. He said some of them cause birth
  defects. There weren't any doctors here, except for
  Dr. Ben, who is being paid by Vince Kwiatkowski to
  write prescriptions for people he had never had.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
Boros's counsel also referred to Dr. Barkin's testimony during
his closing argument, saying: "[I]t just doesn't make sense to
me that you would, as a prosecutor, bring some of this stuff
forward, because . . . somebody like Dr. Barkin, who they
dragged out here, he was very frank, he didn't know a single
thing about this case."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On May 20, 2008, a jury returned a guilty verdict on all three
conspiracy charges. The court sentenced Boros to nine years'
imprisonment, followed by five years of supervised release.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                             <b>II. Discussion</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Boros argues that the district court erred in admitting Dr.
Barkin's testimony because the testimony was not relevant.
Viewing the testimony in the context of the circumstances of
this case, we determine that the testimony had only minimal
relevance as background evidence. While we conclude that the
testimony satisfies <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a>'s low threshold for relevance, we
hold that certain parts of the testimony should have been
excluded under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a> due to their potential for unfair
prejudice. We nevertheless affirm the judgment of the district
court because we conclude that the erroneous admission of Dr.
Barkin's complete testimony was harmless.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>A. Relevance Under Rule 401</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We review a district court's decision to admit or exclude
evidence for abuse of discretion. <i>United States v.</i>
<i>Penaloza</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1G0MUQ003?jcsearch=648%20f%203d%20539&amp;summary=yes#jcite">648 F.3d 539</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1G0MUQ003?jcsearch=648%20f%203d%20539&amp;summary=yes#jcite">544</a> (7th Cir. 2011). We have
recognized that a district court has "wide discretion" when it
rules on the admission of evidence. <i>United States v.</i>
<i>Hall</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X4QAH1?jcsearch=165%20f%203d%201095&amp;summary=yes#jcite">165 F.3d 1095</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X4QAH1?jcsearch=165%20f%203d%201095&amp;summary=yes#jcite">1117</a> (7th Cir. 1999) (quoting
<i>United States v. Wilson</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X4SQ7A?jcsearch=985%20f%202d%20348&amp;summary=yes#jcite">985 F.2d 348</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X4SQ7A?jcsearch=985%20f%202d%20348&amp;summary=yes#jcite">351</a> (7th
Cir. 1993)). We "will not substitute [our] opinion for that of
the trial judge merely because we may be inclined to
rule differently on the question of relevancy." <i>United States v.</i>
<i>Bouye</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X9UE7F?jcsearch=688%20f%202d%20471&amp;summary=yes#jcite">688 F.2d 471</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X9UE7F?jcsearch=688%20f%202d%20471&amp;summary=yes#jcite">476</a> (7th Cir. 1982). <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a> defines
relevant evidence as evidence having "any tendency to make a
fact more or less probable than it would be without the
evidence" and where "the fact is of consequence in determining
the action." FED.R.EVID. <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">401</a>. <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKI003?jcsearch=FED.%20R.%20EVID.%20402&amp;summary=yes#jcite">Rule 402</a> provides the corollary
<span CLASS="page_no" data-cite="2012 bl 35185 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> that, with certain exceptions, "[r]elevant evidence is
admissible" and "[i]rrelevant evidence is not admissible."
FED.R.EVID. <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKI003?jcsearch=FED.%20R.%20EVID.%20402&amp;summary=yes#jcite">402</a>. A party faces a significant obstacle in
arguing that evidence should be barred because it is not
relevant, given that the Supreme Court has stated that there is
a "low threshold" for establishing that evidence is relevant.
<i>Tennard v. Dretke</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XRHSQVQNB5G0?jcsearch=542%20us%20274&amp;summary=yes#jcite">542 U.S. 274</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XRHSQVQNB5G0?jcsearch=542%20us%20274&amp;summary=yes#jcite">285</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XRHSQVQNB5G0?jcsearch=124%20supreme%20court%202562&amp;summary=yes#jcite">124 S.Ct. 2562</a>,
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XRHSQVQNB5G0?jcsearch=159%20l%20ed%202d%20384&amp;summary=yes#jcite">159 L.Ed.2d 384</a> (2004). We have recently asserted that "[t]he
Federal Rules of Evidence do not limit the government to the
`most' probative evidence; all relevant evidence is admissible
and the Rules define relevance broadly." <i>United States v.</i>
<i>McKibbins</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1G86HE003?jcsearch=656%20f%203d%20707&amp;summary=yes#jcite">656 F.3d 707</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1G86HE003?jcsearch=656%20f%203d%20707&amp;summary=yes#jcite">711</a> (7th Cir. 2011).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Boros argues that the district court abused its discretion
because Dr. Barkin's testimony was not relevant. Specifically,
Boros contends that the testimony did not make it any more or
less likely that the conspiracy existed or that Boros knew
about the conspiracy. He argues that the testimony was
introduced only to frighten the jurors with evidence of the
possible
<span CLASS="page_no" data-cite="668 f 3d 908" data-cite-type="PrimaryFederalReporter" data-cite-pageno="908" data-primary-citation="668 F.3d 901">[*908]</span> 
effects of drug use. In response, the government argues
that the testimony was relevant both for background purposes
and for contesting Boros's claim that he did not know that the
operations were illegal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Boros is incorrect in his assertion that evidence is only
relevant if it relates to an element of the offense. <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a>
makes clear that "[e]vidence which is essentially background in
nature can scarcely be said to involve disputed matter, yet it
is universally offered and admitted as an aid to
understanding." FED.R.EVID. <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/1?citation=FREVIDEN%20401&amp;summary=yes#jcite">401</a> advisory committee's note.
Under this theory of relevance, we have explained that one
measure of relevance is whether "its exclusion would leave a
chronological and conceptual void in the story." <i>United</i>
<i>States v. Westbrook</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X36GKP?jcsearch=125%20f%203d%20996&amp;summary=yes#jcite">125 F.3d 996</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X36GKP?jcsearch=125%20f%203d%20996&amp;summary=yes#jcite">1007</a> (7th Cir. 1997)
(quoting <i>Wilson v. Groaning</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X4QNE3?jcsearch=25%20f%203d%20581&amp;summary=yes#jcite">25 F.3d 581</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X4QNE3?jcsearch=25%20f%203d%20581&amp;summary=yes#jcite">584</a> (7th
Cir. 1994)) (internal quotation marks omitted). Thus, even
though evidence may not relate directly to the defendant's
innocence or guilt, or even to a fact in dispute, evidence is
relevant when it provides background information about the
defendant or the offenses charged. Certain background evidence
may touch on ancillary, rather than the core, issues: evidence
of this nature has marginal relevance, but it nonetheless
satisfies <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a>. Yet because background evidence about
ancillary matters has only marginal relevance, it is more
susceptible to exclusion under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a>'s balancing of
prejudice and probative value.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Barkin's testimony falls within the broad category of
background evidence because it aids the jury's understanding of
the substances that PMeds was obtaining, importing, and
selling. The status of the substances as controlled relates to
an element of the offenses. <i>See</i> <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHSRO003?jcsearch=18%20usc%201956&amp;summary=yes#jcite">18 U.S.C. &sect; 1956</a>;
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976D8003?jcsearch=21%20usc%20841&amp;summary=yes#jcite">21 U.S.C. &sect;&sect; 841</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976DK003?jcsearch=21%20U.S.C.%20%20846&amp;summary=yes#jcite">846</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976H8003?jcsearch=21%20U.S.C.%20%20952&amp;summary=yes#jcite">952</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976I2003?jcsearch=21%20U.S.C.%20%20963&amp;summary=yes#jcite">963</a>. The district court's
issuance of a jury instruction on this matter confirms the
relevance of this topic. The remainder of the testimony &mdash;
the prescribed uses, the degree of physician monitoring, the
accessibility, and the side effects &mdash; are arguably
relevant for the purpose of providing a complete background
picture to the jury.<a HREF="#fn600" name="fnref_fn600">[fn6]</a> Whether this ancillary background
evidence is unduly prejudicial &mdash; and thus should have
<span CLASS="page_no" data-cite="2012 bl 35185 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> been excluded &mdash; is not a question that we consider under
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a> but rather under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a>.<a HREF="#fn700" name="fnref_fn700">[fn7]</a>
<span CLASS="page_no" data-cite="668 f 3d 909" data-cite-type="PrimaryFederalReporter" data-cite-pageno="909" data-primary-citation="668 F.3d 901">[*909]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We therefore conclude that the district court did not abuse its
discretion in determining Dr. Barkin's testimony to be
relevant. However, even accepting Dr. Barkin's testimony as
satisfying <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a>, we conclude that parts of his testimony do
not satisfy <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a> and thus should have been excluded.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>B. Prejudice Under Rule 403</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a> permits a district court to "exclude relevant evidence
if its probative value is substantially outweighed by a danger
of . . . unfair prejudice, confusing the issues, misleading the
jury, undue delay, wasting of time, or needlessly presenting
cumulative evidence." FED.R.EVID. <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">403</a>. Recognizing that "`most
relevant evidence is, by its very nature, prejudicial,' we have
emphasized that evidence must be <i>unfairly</i> prejudicial
to require exclusion." <i>United States v. Hanna</i>,
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1EOB2I003?jcsearch=630%20f%203d%20505&amp;summary=yes#jcite">630 F.3d 505</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1EOB2I003?jcsearch=630%20f%203d%20505&amp;summary=yes#jcite">511</a> (7th Cir. 2010) (quoting <i>United States v.</i>
<i>Thomas</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X6CL6N?jcsearch=321%20f%203d%20627&amp;summary=yes#jcite">321 F.3d 627</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X6CL6N?jcsearch=321%20f%203d%20627&amp;summary=yes#jcite">630</a> (7th Cir. 2003)). The amount of
prejudice that is acceptable varies according to the amount of
probative value the evidence possesses. "[T]he more probative
the evidence, the more the court will tolerate some risk of
prejudice, while less probative evidence will be received only
if the risk of prejudice is more remote." <i>United States v.</i>
<i>Vargas</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1AUD0A003?jcsearch=552%20f%203d%20550&amp;summary=yes#jcite">552 F.3d 550</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1AUD0A003?jcsearch=552%20f%203d%20550&amp;summary=yes#jcite">557</a> (7th Cir. 2008) (quoting
<i>United States v. Menzer</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X30EK1?jcsearch=29%20f%203d%201223&amp;summary=yes#jcite">29 F.3d 1223</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X30EK1?jcsearch=29%20f%203d%201223&amp;summary=yes#jcite">1234</a> (7th
Cir. 1994)). We give "special deference" to a district court's
findings under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a>, and we review for abuse of discretion.
<i>See United States v. Moore</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1F95B4003?jcsearch=641%20f%203d%20812&amp;summary=yes#jcite">641 F.3d 812</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1F95B4003?jcsearch=641%20f%203d%20812&amp;summary=yes#jcite">826</a> (7th
Cir. 2011).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court made several comments, which indicated that
it was aware of the prejudice that could result from Dr.
Barkin's testimony. The district court warned, "I don't want
this to get out of control and have him testifying about the
terrible things that can happen to people if they take these
drugs without a prescription, except indicating it factually,
and briefly, and succinctly." But given the limited probative
value of this testimony, the court erred by allowing even
factual, brief, and succinct testimony about the side effects
and birth defects associated with the drugs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The mere acknowledgment that Dr. Barkin's testimony was
relevant under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a> as background evidence does not signify
that all of the testimony passed muster under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a>. When
background evidence is so removed from the focus of the case,
as it was here, even factual, brief, and succinct testimony may
be unfairly prejudicial to the defendant. We have stated that
both probative value and prejudice must be determined in
context. <i>See United States v. Tanner</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1ENQ7O003?jcsearch=628%20f%203d%20890&amp;summary=yes#jcite">628 F.3d 890</a>,
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1ENQ7O003?jcsearch=628%20f%203d%20890&amp;summary=yes#jcite">901-03</a> (7th Cir. 2010) (holding police officers' testimony to be
"unduly prejudicial (and such a waste of time) relative to its
nearly-nonexistent probative value"). The district court does
not appear to have focused on this interaction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Barkin's testimony was relevant because it constituted
background evidence about the regulatory scheme and the dangers
that could result from PMeds's illegal operation. However, this
background evidence bore minimal probative value given the
particular offenses with which Boros was charged. The jury was
asked to determine whether Boros was guilty of conspiracy to
import <span CLASS="page_no" data-cite="2012 bl 35185 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> controlled substances, conspiracy to possess controlled
substances with intent to distribute, and conspiracy
<span CLASS="page_no" data-cite="668 f 3d 910" data-cite-type="PrimaryFederalReporter" data-cite-pageno="910" data-primary-citation="668 F.3d 901">[*910]</span> 
to launder money.<a HREF="#fn800" name="fnref_fn800">[fn8]</a> These offenses do not require the
government to prove that Boros was aware of the regulatory
scheme or the medical risks. These offenses also do not require
proof that anyone was injured as a result of Boros's or his
co-conspirators' conduct. In <i>United States v.</i>
<i>Mansoori</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XANMUR?jcsearch=304%20f%203d%20635&amp;summary=yes#jcite">304 F.3d 635</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XANMUR?jcsearch=304%20f%203d%20635&amp;summary=yes#jcite">654</a> (7th Cir. 2002), we held that
expert testimony about the history and structure of a gang was
admissible as "useful background" and was not unfairly
prejudicial or confusing. We do not reach the same conclusion
as to Dr. Barkin's testimony about the drugs' side effects,
which was less useful and more prejudicial.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We have previously held that evidence showing that defendant's
customers died after buying drugs from him should have been
excluded under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a> because the evidence "had nothing to do
with the charges in th[e] case." <i>United States v.</i>
<i>Cooper</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1CCD96003?jcsearch=591%20f%203d%20582&amp;summary=yes#jcite">591 F.3d 582</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1CCD96003?jcsearch=591%20f%203d%20582&amp;summary=yes#jcite">589</a> (7th Cir. 2010). Dr. Barkin's
testimony is less prejudicial than the testimony in
<i>Cooper</i> because it does not directly connect the side
effects to Boros's customers; however, this disconnect also
confers less probative value on Dr. Barkin's testimony.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  While Dr. Barkin kept his testimony relatively brief and though
his tone was academic rather than emotional, parts of the
content could be described as disturbing. Dr. Barkin discussed
side effects such as seizures, strokes, psychotic episodes, and
birth defects. Dr. Barkin's disclaimer that he did not know any
of PMeds's clients or their side effects does not mitigate his
discussion of the negative consequences that could stem from
the use of the drugs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Evidence bearing minimal probative value is admissible only if
it bears a remote risk of prejudice. <i>See Vargas</i>,
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1AUD0A003?jcsearch=552%20f%203d%20550&amp;summary=yes#jcite">552 F.3d at 557</a>. Dr. Barkin's testimony about the drugs' side
effects and birth defects had a meaningful potential for unfair
prejudice, which substantially outweighed the limited probative
value of the background evidence. We therefore conclude that
the district court abused its discretion in admitting these
parts of the testimony.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>C. Harmless Error Analysis</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Even though we conclude that the district court erroneously
admitted Dr. Barkin's complete testimony, we will "reverse and
order a new trial only if any evidentiary errors are not
harmless." <i>United States v. Boone</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1EOHQ0003?jcsearch=628%20f%203d%20927&amp;summary=yes#jcite">628 F.3d 927</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1EOHQ0003?jcsearch=628%20f%203d%20927&amp;summary=yes#jcite">932</a>
(7th Cir. 2010); <i>see also</i> FED.R.CRIMP. <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KEE003?jcsearch=FED.%20R.%20CRIM.%20P.%2052(a)&amp;summary=yes#jcite">52</a>(a) ("Any
error, defect, irregularity, or variance that does not affect
substantial rights must be disregarded."). In determining
whether the error is harmless, "we consider whether, in the
mind of the average juror, the prosecution's case would have
been significantly less persuasive had the improper evidence
been excluded." <i>United States v. Thornton</i>,
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1FJ7BS003?jcsearch=642%20f%203d%20599&amp;summary=yes#jcite">642 F.3d 599</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1FJ7BS003?jcsearch=642%20f%203d%20599&amp;summary=yes#jcite">605</a> (7th Cir. 2011); <i>see also United States v.</i>
<i>Johnson</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1EDJAC003?jcsearch=624%20f%203d%20815&amp;summary=yes#jcite">624 F.3d 815</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1EDJAC003?jcsearch=624%20f%203d%20815&amp;summary=yes#jcite">819</a> (7th Cir. 2010). To determine
whether an error is harmless, we consider the entirety of the
evidence that the government presented. <i>See McKibbins</i>,
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1G86HE003?jcsearch=656%20f%203d%20707&amp;summary=yes#jcite">656 F.3d at 713</a>. Evidence
<span CLASS="page_no" data-cite="668 f 3d 911" data-cite-type="PrimaryFederalReporter" data-cite-pageno="911" data-primary-citation="668 F.3d 901">[*911]</span> 
erroneously admitted under <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a> warrants reversal only
if its exclusion would have made the jury more likely to acquit
the defendant. <i>See Tanner</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1ENQ7O003?jcsearch=628%20f%203d%20890&amp;summary=yes#jcite">628 F.3d at 902-03</a>. Given
the evidence presented <span CLASS="page_no" data-cite="2012 bl 35185 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> in support of his convictions, Boros has
not established that the government's case would have been
significantly less persuasive to the jury had Dr. Barkin's
improper testimony been excluded.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The government established Boros's guilt through various pieces
of documentary evidence and insider testimony. The letter of
intent identified Boros's role in PMeds. Boros advertised that
PMeds would supply prescription drugs without prescriptions.
Boros sent emails describing the drug supply, suggesting a
supplier, and providing a "usage report" of 235 products,
including controlled substances, by quantity. Moreover, Boros
said nothing to express his surprise or disclaim his
participation when the Calows referenced their illegal actions
over email. Boros responded to an email chain about website
traffic by stating that he was "ready to do a mailing anytime
you want." He expressed no shock or disapproval when Gary
admitted to instructing a "young kid" on how to order an
injectable anabolic steroid. When Larry boasted that PMeds was
"doing great [with] the illegal drugs" and that he also wanted
to have "one legal Pharmacy," Boros again did not express
concern but instead replied that they should "get together" to
"make a plan."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Burdick's testimony also supports Boros's conviction. Based on
her employment at PMeds, which overlapped with Boros's
involvement, she explained how PMeds operated and identified
the roles of the founders. Despite Boros's claim that Burdick's
testimony is uncorroborated, the search of the Tinley Park
office, the evidence related to the controlled buys, the letter
of intent, and the email exchanges all support her testimony.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The testimony from Morrow and Special Agent Desmond also
support the jury's verdict. Morrow testified about the general
nature of the PMeds scheme as designed to import and distribute
anabolic steroids and controlled substances. His testimony was
corroborated by other evidence, including the email exchanges
and his own arrest in 2005 at the border. Special Agent Desmond
testified about the financial operations, including how PMeds
wired money to suppliers in Belize and to people affiliated
with PMeds in Mexico. By Boros's own admission, he received
approximately $47,000 for his participation in PMeds.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The only argument that Boros advances on appeal to refute the
government's case is the testimony from a credit card
processing employee, who stated that Boros had told him to "cut
them off after Boros allegedly discovered PMeds's illegality.
This scant testimony does not counter the amount of evidence
introduced by the government that establishes Boros's
guilt.<a HREF="#fn900" name="fnref_fn900">[fn9]</a>
<span CLASS="page_no" data-cite="668 f 3d 912" data-cite-type="PrimaryFederalReporter" data-cite-pageno="912" data-primary-citation="668 F.3d 901">[*912]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Dr. Barkin's testimony had minimal relevance, minimal probative
value, and over-tones of prejudice. If the evidence as to
Boros's guilt had been less compelling, the government's use of
the testimony relating to the consequences of drug use might
have impacted the outcome of this case. However, in light of
the evidence in support of Boros's guilt, excluding Dr.
Barkin's testimony would not have led an "average juror" <span CLASS="page_no" data-cite="2012 bl 35185 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> to
find that the evidence was "significantly less persuasive."
<i>Cooper</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1CCD96003?jcsearch=591%20f%203d%20582&amp;summary=yes#jcite">591 F.3d at 590</a>. Thus, though we conclude that
the district court should have excluded parts of Dr. Barkin's
testimony, we determine that the evidentiary error was
harmless.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                             <b>III. Conclusion</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For the foregoing reasons, we AFFIRM the judgment of the
district court.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> To avoid confusion, we refer to the Calow brothers by
their first names when we refer to them individually in this
opinion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> Around this time, they also worked to set up
purchasemeds.com, intending for it to be their "one legal
pharmacy."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> The original charges involved conspiracy to distribute
controlled substances with a 28 count indictment returned by
the grand jury.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> The district court later instructed the jury that, as a
matter of law, certain substances are controlled.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> Boros's counsel objected at one point, but the district
court overruled this objection.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> Although we accept the government's argument that Dr.
Barkin's testimony is relevant as background, we reject the
government's alternative argument &mdash; that the testimony is
relevant for disputing Boros's contention that he lacked
knowledge of the pharmacy's illegality. The government's
argument fails because the regulations and risks associated
with these drugs are relevant considerations only if Boros knew
or could be expected to know this information. Only if Boros
knew this information could Dr. Barkin's testimony give rise to
an inference that Boros knew that PMeds was an illegal
pharmaceutical operation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> Boros relies heavily on <i>United States v.</i>
<i>Cunningham</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X15JLMO003?jcsearch=462%20f%203d%20708&amp;summary=yes#jcite">462 F.3d 708</a> (7th Cir. 2006), for the
proposition that certain back ground evidence is not relevant,
but <i>Cunningham's</i> holding and reasoning are inapposite.
In <i>Cunningham</i>, we held that a DEA agent's extensive
testimony about the process he followed to obtain a wiretap,
including numerous probable cause determinations by judges and
government officials, should have been excluded as irrelevant.
<i></i><a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X15JLMO003?jcsearch=462%20F.3d%20708&amp;summary=yes#jcite">Id. at 709</a>. We perceived this testimony as offered
solely to "vouch" for how good the evidence was and to
"bolster" the credibility of unnamed actors. <i></i><a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X15JLMO003?jcsearch=462%20F.3d%20708&amp;summary=yes#jcite">Id.
at 713</a>. We have subsequently declined to apply
<i>Cunningham's</i> holding where wiretap testimony did not
raise these concerns. <i>See, e.g., United States v.</i>
<i>Hendrix</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X184TP0003?jcsearch=509%20f%203d%20362&amp;summary=yes#jcite">509 F.3d 362</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X184TP0003?jcsearch=509%20f%203d%20362&amp;summary=yes#jcite">372-73</a> (7th Cir. 2007). Our concerns
about bolstering and vouching in the wiretap context are not
present here. Moreover, we are guided by <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a> and the
advisory committee's note, which make background evidence
generally admissible as an aid to understanding. Although we
rely in this case on <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKK003?jcsearch=FED.%20R.%20EVID.%20403&amp;summary=yes#jcite">Rule 403</a> while we relied in
<i>Cunningham</i> on <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X135KKG003?jcsearch=FED.%20R.%20EVID.%20401&amp;summary=yes#jcite">Rule 401</a>, our ultimate conclusion is the
same: parts of the evidence should have been excluded from
trial.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> The first count required the government to prove that
Boros conspired to import controlled substances into the United
States with the knowledge that some of those substances were
controlled. <i>See</i> <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976I2003?jcsearch=21%20usc%20963&amp;summary=yes#jcite">21 U.S.C. &sect; 963</a>; <i>see also</i>
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976H8003?jcsearch=21%20usc%20952&amp;summary=yes#jcite">21 U.S.C. &sect; 952</a>. The second count required the government
to prove that Boros conspired to knowingly and intentionally
possess controlled substances with the intent to distribute and
to actually have distributed them. <i>See</i>
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976DK003?jcsearch=21%20usc%20846&amp;summary=yes#jcite">21 U.S.C. &sect; 846</a>; <i>see also</i> <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1976D8003?jcsearch=21%20usc%20841&amp;summary=yes#jcite">21 U.S.C. &sect; 841</a>. The final count
presented to the jury required the government to prove that
Boros conspired to transfer funds out of the United States with
the intent to promote unlawful activity. <i>See</i>
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHSRO003?jcsearch=18%20U.S.C.%20%201956(h)&amp;summary=yes#jcite">18 U.S.C. &sect; 1956</a>(h); <i>see also</i>
<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHSRO003?jcsearch=18%20U.S.C.%20%201956(a)&amp;summary=yes#jcite">18 U.S.C. &sect; 1956</a>(a<a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/XEHSRO003?jcsearch=18%20U.S.C.%20%201956(c)&amp;summary=yes#jcite">)-(c)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn900" name="fn900">[fn9]</a></span> Furthermore, we are not persuaded by Boros's argument
that the prosecutor's closing remarks constitute an error that
requires vacating the conviction. Boros relies on
<i>Arrieta-Agressot v. United States</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X3MSCN?jcsearch=3%20f%203d%20525&amp;summary=yes#jcite">3 F.3d 525</a>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X3MSCN?jcsearch=3%20f%203d%20525&amp;summary=yes#jcite">527</a>
(1st Cir. 1993), in which the prosecutor repeatedly urged the
jury to view the case "as a battle in the war against drugs,
and the defendants as enemy soldiers." <i><a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X3MSCN?jcsearch=3%20F.3d%20525&amp;summary=yes#jcite">Id</a>.</i> The First
Circuit held that the remarks constituted prosecutorial
misconduct and vacated the convictions, noting that the
government's evidence was "not overwhelming" and that "the
threat was that the prosecutor's remarks would excite the jury,
invite a partisan response, and distract its attention" from
deciding whether the evidence established the defendants'
guilt. <i></i><a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X3MSCN?jcsearch=3%20F.3d%20525&amp;summary=yes#jcite">Id. at 529-30</a>. Here, in contrast, not only did
the government present substantial evidence of Boros's guilt,
but the prosecutor's remarks were also not as inflammatory or
political as in <i>Arrieta-Agressot.</i> The prosecutor's
closing did not label Boros as the cause of societal problems
or call on the jury to save society from the evil of drugs.
<i>See Arrieta-Agressot</i>, <a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X3MSCN?jcsearch=3%20f%203d%20525&amp;summary=yes#jcite">3 F.3d at 527</a>. The First Circuit
addressed a different legal framework and different set of
facts. Although we do not condone the government's approach,
the closing remarks do not require vacating Soros's
convictions.
</p></div>
</div>
<!--BBLS DD 1688404819971-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1H4ECA003/history">Direct History (2)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1H4ECA003/analysis">Case Analysis (19)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1H4ECA003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
19
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Conviction Affirmed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/dca4362e458aae3a923324d93b2455ff/document/X1Q6LCARVV82">10-02566 (7th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Criminal Law</div><div class='facetItemLabel'>Evidence</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/dca4362e458aae3a923324d93b2455ff/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "dca4362e458aae3a923324d93b2455ff";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY541c58&previousPageId=&previousActivityInstanceId=ENTITY0d84e7&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:31:30-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1H4ECA003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY0d84e7&previousPageId=&previousActivityInstanceId=ENTITY7de49d&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:31:28-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1H4ECA003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1H4ECA003";
$('#page_loader').show().spin();
JUDGE_IDS=["1863678","2573485"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
